MCM
PTLA

Moore Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Moore Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-78,947
Closed -$1.89M – 296
2019
Q4 		$1.89M Sell
78,947
-136,262
-63% -$3.76M 0.06% 193
2019
Q3 		$5.77M Buy
+215,209
New +$6.04M 0.23% 126
2019
Q2 		– Sell
-150,488
Closed -$5.22M – 415
2019
Q1 		$5.22M Buy
+150,488
New +$4.34M 0.16% 129

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Moore Capital Management's PTLA Position: Q1 2020 in Review

Moore Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 78,947 shares — an estimated $1.89M sold.

Moore Capital Management first reported a position in PTLA in Q1 2019 and held it in 3 quarters. The position peaked at $5.77M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Moore Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Moore Capital Management sold 78,947 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.89M.
  • Moore Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2019 and held it in 3 quarters.
  • Moore Capital Management's Portola Pharmaceuticals, Inc. position peaked at $5.77M in Q3 2019.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Moore Capital Management's 13F filing for Q1 2020, filed 15 May 2020.